Abstract
The anti-inflammatory effect of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with inhibition of cyclooxygenase (COX), the rate-limiting enzyme responsible for the synthesis of prostaglandins. Since oxygen free radicals can act as second cellular messengers, especially to modulate the metabolism of arachidonic acid and the prostaglandin tract, it seems plausible that antioxidants might affect the production of prostaglandin by activated cells. This research is focused on the effect of the antioxidant N-acetylcysteine (NAC) on the inhibition of prostaglandin E(2) formation in activated monocytes by specific and non-specific COX inhibitors. We found that lipopolysaccharide-induced prostaglandin E(2) formation was significantly reduced by rofecoxib and by diclofenac, two NSAIDs. Addition of NAC to each of these drugs enhanced the effect of the NSAIDs. These results suggest that one might expect either a potentiation of the anti-inflammatory effect of COX inhibitors by their simultaneous administration with NAC, or obtaining the same anti-inflammatory at lower drug levels.
Full Text
The Full Text of this article is available as a PDF (157.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abate A., Yang G., Dennery P. A., Oberle S., Schröder H. Synergistic inhibition of cyclooxygenase-2 expression by vitamin E and aspirin. Free Radic Biol Med. 2000 Dec;29(11):1135–1142. doi: 10.1016/s0891-5849(00)00425-1. [DOI] [PubMed] [Google Scholar]
- Chinery R., Beauchamp R. D., Shyr Y., Kirkland S. C., Coffey R. J., Morrow J. D. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res. 1998 Jun 1;58(11):2323–2327. [PubMed] [Google Scholar]
- Feng L., Xia Y., Garcia G. E., Hwang D., Wilson C. B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest. 1995 Apr;95(4):1669–1675. doi: 10.1172/JCI117842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawkey C. J. COX-2 inhibitors. Lancet. 1999 Jan 23;353(9149):307–314. doi: 10.1016/s0140-6736(98)12154-2. [DOI] [PubMed] [Google Scholar]
- Hoffer E., Shenker L., Baum Y., Tabak A. Paraquat-induced formation of leukotriene B4 in rat lungs: modulation by N-acetylcysteine. Free Radic Biol Med. 1997;22(3):567–572. doi: 10.1016/s0891-5849(96)00385-1. [DOI] [PubMed] [Google Scholar]
- Hoffman T., Brando C., Lizzio E. F., Lee C., Hanson M., Ting K., Kim Y. J., Abrahamsen T., Puri J., Bonvini E. Functional consequences of phospholipase A2 activation in human monocytes. Adv Exp Med Biol. 1990;279:125–136. doi: 10.1007/978-1-4613-0651-1_8. [DOI] [PubMed] [Google Scholar]
- Kröger H., Hauschild A., Ohde M., Bache K., Voigt W. P., Ehrlich W. Enhancing the inhibitory effect of nicotinamide upon collagen II induced arthritis in mice using N-acetylcysteine. Inflammation. 1999 Apr;23(2):111–115. doi: 10.1023/a:1020284810976. [DOI] [PubMed] [Google Scholar]
- Laufer S., Zechmeister P., Klein T. Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitors. Inflamm Res. 1999 Mar;48(3):133–138. doi: 10.1007/s000110050436. [DOI] [PubMed] [Google Scholar]
- Lee S. H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992 Dec 25;267(36):25934–25938. [PubMed] [Google Scholar]
- Warner T. D., Giuliano F., Vojnovic I., Bukasa A., Mitchell J. A., Vane J. R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7563–7568. doi: 10.1073/pnas.96.13.7563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wittenborg A., Petersen G., Lorkowski G., Brabant T. Wirksamkeit von Vitamin E im Vergleich zu Diclofenac-Natrium in der Behandlung von Patienten mit chronischer Polyarthritis. Z Rheumatol. 1998 Aug;57(4):215–221. doi: 10.1007/s003930050094. [DOI] [PubMed] [Google Scholar]